DrugPatentWatch Database PreviewSee Plans and Pricing
« Back to Dashboard
Faropenem is an investigational drug.
There have been 8 clinical trials for Faropenem. The most recent clinical trial was a Phase 2 trial, which was initiated on December 1st 2005.
The most common disease conditions in clinical trials are Tuberculosis, Tuberculosis, Pulmonary, and Pneumonia. The leading clinical trial sponsors are Jiangsu Chia-tai Tianqing Pharmaceutical Co.,Ltd, National University Hospital, Singapore, and Replidyne.
Recent Clinical Trials for Faropenem
|Phase 2a Study Early Bactericidal Activity of Rifampin + Meropenem + Amoxicillin/Clavulanate in Adults With Pulmonary TB||Johns Hopkins University||Phase 2|
|Early Bactericidal Activity Study of Faropenem(With Amoxicillin/Clavulanic Acid)in Patients With Pulmonary Tuberculosis||National University Hospital, Singapore||Phase 2|
|Whole Blood Bactericidal Activity (WBA) Against Mycobacterium Tuberculosis of Faropenem Plus Amoxicillin/Clavulanic Acid in Healthy Volunteers||National University Hospital, Singapore||Phase 1|